Researchers have developed an artificial spleen that cleans up blood infections
Researchers have developed an
artificial spleen that cleans up blood infections
Posted by:
Deepak Kumar
A new device can clean up blood infections and
remove “everything from E. coli to Ebola”.
Scientists
from the US have developed a new, high-tech device that can clear infections
from blood - even those caused by unknown pathogens.

Blood infections
are extremely difficult to treat and can lead to sepsis - an extreme immune
response that can be fatal. More than half of the time, doctors don’t know what
causes these blood infections, and they have to rely on broad-scale antibiotics
in an attempt to treat the original infection, Reardon explains. This isn’t
always effective, and can lead to antibiotic resistance.
But this new
artificial “biospleen”, developed by a team of researchers led by Donald Ingber
from Harvard University’s Wyss Institute for Biologically Inspired Engineering
in Boston, promises to filter the blood and get rid of these infections more
effectively.
The device's
power lies in a special, magnetic-nanobead filter. To create the filter, the
scientists took magnetic nanobeads and coated them with a modified version of a
protein called mannose-binding lectin (MBL). This protein is found in humans
and it binds to sugar molecules on the surface of more than 90 different
bacteria, viruses and fungi - including the toxins that dead bacteria release,
which can trigger sepsis.
As a
patient’s blood passes through the biospleen, these MBL-coated magnetic
nanobeads bind to the majority of pathogens. A magnet in the artificial spleen
then pulls the beads and the bacteria and viruses they’re attached to out of
the blood, leaving the blood purified and ready to be pumped back into the
patient.
The device
has now been tested on rats infected with either E. coli or Staphylococcus
aureus. Five hours after infection, 89% of the rats whose blood had been
filtered through the biospleen were still alive, compared to only 14% of those
who were not treated. Impressively, the scientists found that the device had
removed more than 90% of the bacteria from the rats’ blood. The results are
published in Nature Medicine.
“The rats
whose blood had been filtered also had less inflammation in their lungs and
other organs, suggesting they would be less prone to sepsis,” writes Reardon.
The team
then tested the biospleen on five litres of blood, which is the volume in the
average human, and found that within five hours, the device could remove most
pathogens.
Reardon
explains at Nature News: “That degree of efficacy is probably enough to control
an infection, Ingber says. Once the biospleen has removed most pathogens from
the blood, antibiotics and the immune system can fight off remaining traces of
infection — such as pathogens lodged in the organs, he says.”
The
biospleen could also be used to treat viral infections such as HIV and Ebola,
according to Ingber, and testing as now begun in pigs.
Nigel Klein,
an infection and immunity expert at University College London in the UK, told
Reardon that he expects the biospleen could be trialled in humans within a
couple of years.